Down syndrome and thyroid dysfunction: should nutritional support be the first-line treatment?

Area of Science:

• Endocrinology
• Genetics
• Nutritional Science

Background:

• Individuals with Down syndrome (DS) exhibit an elevated risk for hypothyroidism, including a specific mild neonatal form.
• Overexpression of the DYRK1A gene in trisomy 21 may contribute to thyroid dysfunction.
• Thyroxine supplementation, while common, presents potential positive and negative effects.

Purpose of the Study:

• To explore nutritional interventions as a primary treatment for hypothyroidism in Down syndrome.
• To compare the efficacy and safety of nutritional support versus thyroxine therapy.
• To investigate the potential benefits of prenatal nutritional interventions for thyroid health in DS.

Main Methods:

• Review of historical and contemporary clinical practices regarding nutritional support for hypothyroidism in DS.
• Analysis of the potential impact of specific nutrients (iodine, L-tyrosine, selenium, zinc) and bovine glandulars on thyroid function.
• Hypothesizing the role of prenatal maternal nutrition.

Main Results:

• Nutritional support for hypothyroidism has been safely utilized for decades in individuals with DS.
• Nutritional interventions offer benefits similar to drug therapy without the associated negative long-term effects.
• Historical use of bovine glandulars and modern inclusion of specific nutrients suggest a supportive role for thyroid function.

Conclusions:

• Nutritional thyroid support should be considered a first-line treatment option for Down syndrome, potentially preceding or replacing thyroxine therapy.
• Prenatal nutritional interventions by mothers may offer protective benefits for thyroid health in offspring with DS.
• Further research into nutritional strategies for managing hypothyroidism in Down syndrome is warranted.